The list below contains Medical Device’s Field Corrective Action for the month of January 2024. This list provides field corrective action reporting information to MDA by establishment in accordance to requirement stipulated in Section 41, Act 737 and Regulation 6 of Medical Device (Duties and Obligations of Establishment) Regulations 2019.

Field Corrective Action (FCA) is part of a post-marketing risk assessment measure to ensure the continued safe use of medical devices in the Malaysia market. It is a corrective or preventive action in relation to a medical device which may include –

  • The return of the medical device to the establishment;
  • Modification of the medical device;
  • Exchange of the medical device;
  • Destruction of medical device; or
  • Specific advice on the use of the medical device. 

If you have experienced any safety and performance issue with one of the medical devices listed for FCA action, please seek advice from your medical device authorised representative as soon as possible.

 

No

Date received

Title of FCA

Affected

Medical Device

MDA Reference Number

MDA Registration Number

Description

Local Establishment

Contact Detail

1

25 Jan 2024

3M SURGICAL CLIPPER BLADE ASSEMBLY - Medical Device Safety Notification

3M SURGICAL CLIPPER WITH PIVOT HEAD

MDA/FCA/P0652-77922719-2024

GA67353133017

This safety notification has been initiated to disclose maximum potential temperature of the clipper blades during use and the conditions for safe contact to be in compliance with the IEC 60601-1 standard and further reduce the potential for injury.

CHUAH CHIEW TENG

SENIOR EHS & REGULATORY MANAGER

3M MALAYSIA SDN BHD

2

23 Jan 2024

Urgent Field Safety Notice on the transcription errors on the Instruction for Use (IFU) for the Calibration Serum Level 3, CAL2351 (Lot No:1262UE)

CALIBRATION SERUM

MDA/FCA/P0630-86304190-2023

IVDB241627216

Randox Laboratories has identified that CK Total in Calibration Serum Level 3, CAL2351 is running with a positive bias on RX Series instruments compared to other methods. We have reassigned that target values in the above lot numbers in line with both the IFCC and DGKC reference materials.

NURAISYAH BINTI AHMAD SHUKRI

REGULATORY AFFAIRS & QUALITY ASSSURANCE SPECIALIST

ANDAMAN MEDICAL BRIDGE SDN. BHD.

3

24 Jan 2024

Urgent Field Safety Notice on the transcription errors on the Instruction for Use (IFU) for the Human Assayed Multisera Level 2, HN1530 (Lot No: 1593UN)

HUMAN ASSAYED MULTI-SERA

MDA/FCA/P0631-13390491-2023

IVDC53152117318

Randox Laboratories can confirm that there have been transcription errors on the Instruction For Use (IFU) for Human Assayed Multi-Sera Level 2, HN1530, for the lots listed in the Urgent Field Safety Notice (complaint reference REC701, Part 3).

NURAISYAH BINTI AHMAD SHUKRI

REGULATORY AFFAIRS & QUALITY ASSSURANCE SPECIALIST

ANDAMAN MEDICAL BRIDGE SDN. BHD.

4

1 Feb 2024

Possible overfilling of the humidifier due to incorrectly installed refill hose by the operator

SOPHIE

MDA/FCA/P0658-66644416-2024

GC8951523-136057

If the amount of water flowing down is too large, this is detected by the Sophie's level sensors and indicated by the high-priority alarm "Water level high". In extreme cases, this can cause the water to overflow into the ventilation tubes. In this situation, starting mechanical ventilation may pose an unacceptable risk to the patient.

KHO BENG TEIK

FRITZ STEPHAN SOUTHEAST ASIA SDN BHD

5

1 Feb 2024

Potential hazard of device failure due to defective heater cable.

SOPHIE

MDA/FCA/P0666-26434884-2024

GC8951523-136057

The “measure menu” in the display of a Sophie ventilator was opened without the user input. This behaviour can be caused by an inadvertent contact of the heater cable live wire with the wire mesh shielding, in this case of a defect or an inappropriate repair of the breathing circuit heater wires or its adapter cable.

KHO BENG TEIK

FRITZ STEPHAN SOUTHEAST ASIA SDN BHD

6

2 Jan 2024

Patient allergies deleted from external systems are displayed in Centricity Critical Care (CCC), Centricity Anesthesia (CA), Centricity High Acuity Anesthesia (CHA-A) and Centricity High Acuity Critical Care (CHA-CC) products.

CENTRICITY HIGH ACUITY CRITICAL CARE

MDA/FCA/P0643-25003408-2024

GMD17215498118A

Centricity Critical Care (CCC), Centricity Anesthesia (CA), Centricity High Acuity Anesthesia (CHA-A) and Centricity High Acuity Critical Care (CHA-CC) products do not support deleting patient allergies via interface messaging. Once a patient allergy is imported, the data will remain in the CCC, CA, or CHA system even when deleted from the external system, leading to a potential mismatch of patient allergy information between the two systems. This could lead to suboptimal treatment of patients.

LIM SOCK SIANG

DIRECTOR

GE HEALTHCARE SDN. BHD

7

2 Jan 2024

Double image artifact with IC9-RS intracavitary probes

LOGIQ P SERIES (LOGIQ P8, LOGIQ P9, LOGIQ P10)

MDA/FCA/P0644-90383262-2024

GB4889221-73580

GE HealthCare has become aware of an issue with certain IC9-RS ultrasound probes that can result in a double image artifact creating a ghost image with realistic features. An unrecognized artifact may lead to misdiagnosis.

LIM SOCK SIANG

DIRECTOR

GE HEALTHCARE SDN. BHD

8

30 Jan 2024

Notification on COV applied parts

ASTOPAD SYSTEM

MDA/FCA/P0662-24598313-2024

GB56556811018

COV applied parts manufactured from May 2022 to October 2023 may potentially have internal (not visible from outside) damaged electrical insulation at a few distinct locations. The root cause is an error in the manufacturing process of the heating element. The damage could lead to localized overheating. This was identified during internal investigation after a single reported adverse event in which a patient received a burn approx. 3 cm in diameter.

DEVANDRAN KAMELA KUMARAN

OPERATIONS MANAGER

GEMILANG ASIA TECHNOLOGY SDN BHD

9

15 December 2023

FSN 2023-IGT-BST-005 Azurion 5 Philips Azurion System 81.0, 81.1, 81.2, 82.0, R2.1, and R2.2 Potential loss of imaging functionality and clinical data stored in the system.

AZURION 5

MDA/FCA/P0619-77026117-2023

GC10785320-48186

If this issue occurs, the Philips Azurion system might not recover from this fault situation causing the system to not be available. If the issue occurs during a procedure, there may be a delay and/or abortion of the procedure.

ZAM ZARINA BINTI MAT AIL

QUALITY & REGULATORY MANAGER

PHILIPS MALAYSIA SDN BERHAD

10

15 December 2023

AZURION 7

MDA/FCA/P0620-67529325-2023

GC82521235717

11

15 December 2023

FSN 2023-IGT-BST-020Azurion 7 M20 FlexArm system with Maquet Magnus Table Unavailable Motorized Table and/or FlexArm Movement Potentially Resulting in Delay or Termination of Procedure

AZURION 7

MDA/FCA/P0621-79365512-2023

GC82521235717

The connection between the FlexArm and the Table may not reestablish if the detector continues to be at approximately four (4) cm from the patient when the Table restarts. This will result in a recurring connection loss between the FlexArm and the Table, during which Table movement will be unavailable.

ZAM ZARINA BINTI MAT AIL

QUALITY & REGULATORY MANAGER

PHILIPS MALAYSIA SDN BERHAD

12

15 December 2023

FSN 2023-PD-DXR-013 ProxiDiagnost N90 1.1 and ProxiDiagnost Upgrade Software Defects causing imaging issues during Radiography and Fluoroscopy examination

PROXIDIAGNOST N90

MDA/FCA/P0625-42844469-2023

GC625521251919

Issue 1: Mixed Images: Philips has identified that the Radio Fluoroscopy (RF) viewer may also display a previous patient’s radiography (RAD) images when starting the next patient scan while the previous patient image export is still processing.

Issue 2: Detector Access point: Philips has identified a security vulnerability specific to the Wireless Portable Detector configuration items in Philips Support Connect (PSC).

ZAM ZARINA BINTI MAT AIL

QUALITY & REGULATORY MANAGER

PHILIPS MALAYSIA SDN BERHAD

13

12 Jan 2024

2023-IGT-BST - 027 Allura Xper PC Issues Potential Loss of System Functionality which May Result in Delay or Termination of Procedure

ALLURA XPER FD OR TABLE SERIES

MDA/FCA/P0645-67536477-2024

GC97115121117

A loss of imaging functionality could result in a delay of the procedure (including termination of the procedure, should performing a cold restart not temporarily restore system functionality).

ZAM ZARINA BINTI MAT AIL

QUALITY & REGULATORY MANAGER

PHILIPS MALAYSIA SDN BERHAD

14

5 Jan 2024

2023-IGT-BST - 027 ALLURA CENTRON PC Issues Potential Loss of System Functionality which May Result in Delay or Termination of Procedure

ALLURA CENTRON

MDA/FCA/P0646-34846840-2024

GC67062225117

A loss of imaging functionality could result in a delay of the procedure (including termination of the procedure, should performing a cold restart not temporarily restore system functionality). The potential delay in treatment and/or termination of the procedure may result in serious adverse health outcomes, including the possibility of death, especially when the system is used with some of the most critical patients

ZAM ZARINA BINTI MAT AIL

QUALITY & REGULATORY MANAGER

PHILIPS MALAYSIA SDN BERHAD

15

5 Jan 2024

2023-IGT-BST - 027 AZURION 3 PC Issues Potential Loss of System Functionality which May Result in Delay or Termination of Procedure

AZURION 3

MDA/FCA/P0647-54139757-2024

GC99381544218

A loss of imaging functionality could result in a delay of the procedure (including termination of the procedure,should perform a cold restart not temporarily restore system functionality). The potential delay in treatment and/or termination of the procedure may result in serious adverse health outcomes, including the possibility of death, especially when the system is used with some of the most critical patients

ZAM ZARINA BINTI MAT AIL

QUALITY & REGULATORY MANAGER

PHILIPS MALAYSIA SDN BERHAD

16

5 Jan 2024

AZURION 7

MDA/FCA/P0648-44882004-2024

GC82521235717

17

15 Jan 2024

FSN_2023-PD-MR-013 MR systems with 60cm wide bore Quadrature Body Coil (QBC) seal adhesive failure may result in exposure of sharp edges

ACHIEVA SERIES

MDA/FCA/P0653-64995794-2024

GB44884842218

If the QBC seal becomes loose during the scanning process, the risk to the patient may include one or more of the following: skin abrasions, bruises, lacerations, hair loss/entanglement, and tissue injury.

ZAM ZARINA BINTI MAT AIL

QUALITY & REGULATORY MANAGER

PHILIPS MALAYSIA SDN BERHAD

18

22 Jan 2024

012 CN AIMC 24-05 Atellica IM T4 Assay -  Atellica IM Total Thyroxine (T4) Assay Master Curve Card Scanning Error

ATELLICA® IM TOTAL THYROXINE (T4)

MDA/FCA/P0659-56763739-2024

IVDB79506172418

The purpose of this communication is to inform you of an issue with the product indicated in Table 1 below and provide instructions on actions that your laboratory must take. Siemens Healthcare Diagnostics Inc. has confirmed an inability to successfully scan the master curve card (MCC) packaged with Total Thyroxine (T4) Assay Kit Lots 07485274 or 07444274 on the Atellica IM analyzer with Software Version 1.26 and below. An analyzer error message is generated and prevents customers from testing with these assay kit lots.

LAM YEN LI

HEAD OF QUALITY & TECHNOLOGY

SIEMENS HEALTHCARE SDN. BHD.

19

29 Jan 2024

013 FSCA AIMC 24-04 Atellica IM Erythropoietin (EPO) Negative Bias

ATELLICA IM ERYTHROPOIETIN (EPO)

MDA/FCA/P0661-78937518-2024

IVDB5198820-45185

Siemens Healthcare Diagnostics has confirmed an average negative bias of -35% compared to the 3rd World Health Organization (WHO) International Standard (NIBSC code: 11/170) that is proportional across the assay measuring interval.

LAM YEN LI

HEAD OF QUALITY & TECHNOLOGY

SIEMENS HEALTHCARE SDN. BHD.

20

1 Feb 2024

014 FSCA POC 24-007 - Atellica® UAS 800/Atellica 1500 Analyzer Misidentification of Sample IDs

ATELLICA UAS 800 ANALYZER

MDA/FCA/P0664-62786290-2024

IVDB43102172618

Siemens Healthcare Diagnostics Inc. has confirmed an issue that has the potential to misidentify samples when ALL the following specific conditions are met:

• the cuvettes run out after the start of or in the middle of sample analysis, AND

• the user presses the “Continue” button within 3 seconds of the button enabling to reinitiate analysis after cuvette replacement, AND

• the barcode reader does not detect a barcode (either due to a non-existent or poor-quality barcode).

LAM YEN LI

HEAD OF QUALITY & TECHNOLOGY

SIEMENS HEALTHCARE SDN. BHD.

21

26 Jan 2024

SAFETY ALERT LIFEPAK® 15 AC Power Adapter Will Not Charge Batteries of Power Device

LIFEPAK 15

MDA/FCA/P0592-33505735-2023

GC11512940618

Stryker has identified an increase in the number of complaints related to the LP15 ACPA failures with the reported symptoms of “Battery Not Charging” and “Auxiliary Power Will Not Power Device or Charge Batteries”. This issue is only applicable to ACPAs used on 110V power grids.

NURUL AIN BINTI MAT RIPING

MANAGER

SIXMURS MALAYSIA SDN. BHD.

22

15 Dec 2023

HemosIL® von Willebrand Factor Antigen (PN 0020002300), All Product Lots, Reduced Open Vial Stability Claim to 14 Days at 2-8°C

HEMOSIL VON WILLEBRAND FACTOR ASSAY KITS

MDA/FCA/P0624-55850331-2023

IVDB17919408719

Our investigation into reported customer complaints identified that the product was not meeting its labelled claim for Open vial stability at 2-8°C of 3 months. A new open vial stability claims of 14 days at 2-8°C was established and cleared by the FDA.

CHAI AI LIN

MANAGER

STRAITS SCIENTIFIC (M) SDN BHD